DOI: 10.12890/2021_002194
Mesalazine-induced Hypersensitivity Pneumonitis
Authors
afranciscamp@gmail.com
Keywords
Mesalazine, ulcerative colitis, drug reaction, hypersensitivity pneumonitis, lung injuryAbstract
A 57-year-old woman with Crohn's disease (ulcerative proctitis) treated with mesalazine (5-ASA) developed worsening respiratory distress and cough. The lack of response to antibiotics and the results of bronchoalveolar lavage led to the diagnosis of mesalazine-related hypersensitivity pneumonitis, an infrequent entity. Symptoms improved after discontinuation of mesalazine and the administration of corticosteroid therapy. The authors discuss the diagnosis and management of this rare condition.
References
- Huang PH, Kuo CJ, Lin CW, Cheng YM, Hu HC, Lin CY, et al. Mesalazine-related lung disease in a patient with ulcerative colitis: a case report. Medicine (Baltimore) 2018;97(48):3–6.
- Kacprzak A, Siemion-Szcze?niak I, Szturmowicz M, Bestry I, Langfort R, Ku? J. Pulmonary pathology in patients with ulcerative colitis treated with mesalazine—a challenging and complex diagnostic problem. Case series and literature review. Pneumonol Alergol Pol 2014;82(4):368–376.
- Kotsiou OS, Gourgoulianis KI. A case report of mesalazine-induced lung injury: a reversible drug side effect. Respir Med Case Rep 2019;27:100865.
- Fouka E, Stefanopoulo P, Dramba V, Bombotas D. Acute interstitial lung disease in a patient with ulcerative colitis: case report and literature review. Pneumon 2012;25(3):320–324.
- Bitton A, Peppercorn MA, Hanrahan JP, Upton MP. Mesalamine-induced lung toxicity. Am J Gastroenterol 1996;91(5):1039–1040.
Published
2021-01-07
Issue
How to Cite
1.
Pereira A, Marques C, Boncoraglio T, Esteves J, Silva M, Braga J, et al. Mesalazine-induced Hypersensitivity Pneumonitis . EJCRIM [Internet]. 2021 Jan. 7 [cited 2026 Nov. 3];8(1). Available from: https://ejcrim.com/index.php/ejcrim/article/view/2194
